Literature DB >> 35535152

Corrigendum to "Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS".

Ming Qiao1, Jianhua Yang2, Yao Zhao1, Yi Zhu2, Xiaomei Wang1, Xinling Wang1, Junping Hu1.   

Abstract

[This corrects the article DOI: 10.1155/2020/8321732.].
Copyright © 2022 Ming Qiao et al.

Entities:  

Year:  2022        PMID： 35535152      PMCID： PMC9078777          DOI： 10.1155/2022/9818920

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN： 1741-427X            Impact factor:   2.650


In the article titled “Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS” [1], concerns regarding duplicate images in Figure 1 were raised on PubPeer [2]. Specifically, Figures 1(c) and 1(d) appear to be identical. The authors explained that this duplication occurred due to an error introduced during the preparation of the manuscript and have provided a corrected image for Figure 1(c), shown as follows.
Figure 1
  1 in total

1.  Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS.

Authors:  Ming Qiao; Jianhua Yang; Yao Zhao; Yi Zhu; Xiaomei Wang; Xinling Wang; Junping Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-18       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.